Modified USP assay for simultaneous determination of aspirin and nonaspirin salicylates in aspirin and buffered aspirin tablets.
Modified USP procedures are described for the simultaneous determination of nonaspirin salicylates and aspirin in aspirin and buffered aspirin tablets. The existing USP procedures are not stability indicating for intact aspirin when significant levels of nonaspirin salicylates are present, as is often the case in short-term, high temperature stability programs. The modified procedures yeld considerably shorter analysis times and stability-indicating assays for intact aspirin without the need for sophisticated equipment other than that presently required by USP XIX.
D001241:Aspirin / Q000032:analysis*; D002021:Buffers; D004355:Drug Stability; D007202:Indicators and Reagents; D000432:Methanol; D008722:Methods; D010602:Pharmacopoeias as Topic; D012459:Salicylates / Q000032:analysis*; D013607:Tablets / Q000032:analysis; D014481:United States
D002021:Buffers; D007202:Indicators and Reagents; D012459:Salicylates; D013607:Tablets; D001241:Aspirin; D000432:Methanol